help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiosano, D.
Right arrow Articles by Hochberg, Z.'e.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiosano, D.
Right arrow Articles by Hochberg, Z.'e.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 1908-1912
Copyright © 2001 by The Endocrine Society


Original Studies

The Role of the Vitamin D Receptor in Regulating Vitamin D Metabolism: A Study of Vitamin D-Dependent Rickets, Type II

Dov Tiosano1, Yosef Weisman and Ze’ev Hochberg

Department of Pediatrics, Rambam Medical Center, Haifa 31096, Israel; and Bone Disease Unit, Tel-Aviv Medical Center (Y.W.), Tel-Aviv 64230, Israel

Address all correspondence and requests for reprints to: Dr. Dov Tiosano, Rambam Medical Center, POB 9602, Haifa 31096, Israel. E-mail: d_tiosano{at}rambam.health.gov.il

In vitro studies and animal experiments suggest that the production of 1,25-dihydroxyvitamin D [1,25-(OH)2D] and 24,25-(OH)2D is reciprocally controlled by 1,25-(OH)2D. To investigate the role of the vitamin D receptor (VDR) in controlling vitamin D metabolism in humans, we studied 10 patients with vitamin D-dependent rickets type II due to a defective VDR. After a period of high dose calcium therapy, 7 of the patients had normal serum calcium, phosphorus, alkaline phosphatase, and plasma PTH levels (PTH-N), and 3 showed increased serum alkaline phosphatase and plasma PTH (PTH-H). Serum calcium, phosphorus, alkaline phosphatase, PTH, vitamin D metabolites, urinary calcium/creatinine, and renal phosphate threshold concentration were compared with unaffected family members that comprised the control group. Vitamin D metabolites were measured before and after an oral load of 50,000 U/m2 cholecalciferol. Compared with the control group, 1,25-(OH)2D levels were significantly higher and 24,25-(OH)2D levels were lower in the PTH-N group and even more so in the PTH-H group. 1{alpha}-Hydroxylase (1-OHase) and 24-OHase activities were estimated by the product/substrate ratio. In the PTH-N group, 1-OHase activity was higher and 24-OHase activity was lower than in controls. In the PTH-H group, 1-OHase activity was even higher, probably due to an additive effect of PTH. Thus, 1,25-(OH)2D-liganded VDR is a major control mechanism for vitamin D metabolism, and PTH exerts an additive effect. Assessment of the influence of 1,25-(OH)2D shows reciprocal control of enzyme activity in man, suppressing 1-OHase and stimulating 24-OHase activity.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. I. Baroncelli, A. Bereket, M. El Kholy, L. Audi, Y. Cesur, B. Ozkan, M. Rashad, M. Fernandez-Cancio, Y. Weisman, G. Saggese, et al.
Rickets in the Middle East: Role of Environment and Genetic Predisposition
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1743 - 1750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society